LYMPHVASCULAR SPACE INVOLVEMENT - A PROGNOSTIC INDICATOR IN ENDOMETRIAL ADENOCARCINOMA

被引:78
|
作者
GAL, D
RECIO, FO
ZAMUROVIC, D
TANCER, ML
机构
[1] SUNY HLTH SCI CTR BROOKLYN,BROOKLYN,NY
[2] MAIMONIDES HOSP,DEPT GYNECOL ONCOL,BROOKLYN,NY 11219
[3] MAIMONIDES HOSP,DEPT PATHOL,BROOKLYN,NY 11219
[4] MAIMONIDES HOSP,DEPT OBSTET & GYNECOL,BROOKLYN,NY 11219
关键词
D O I
10.1016/0090-8258(91)90334-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study evaluates the effects of various prognostic indicators on survival of patients with clinical Stage I endometrial carcinoma. Ninety-three patients who were treated for clinical Stage I endometrial adenocarcinoma at Maimonides Medical Center from October 1979 to October 1987 had sufficient surgical-pathological information for retrospective surgical staging according to the new FIGO classification. Histology was reviewed. A new grade and surgical stage was assigned to each patient in accordance with the recent FIGO guidelines for surgical staging of corpus cancer. Poor prognostic indicators, namely, tumor grade, depth of myometrial invasion, peritoneal cytology, lymph node metastases, and lymphvascular space (LVS) involvement, were correlated with 5-year survival rates. Survival rates were calculated by the life table method. Depth of myometrial invasion, lymph node involvement, and peritoneal cytology had significant statistical correlation with poor survival. Positive finding of each of the prognostic indicators, including LVS involvement, was significantly associated with poor survival (all P < 0.001). The value of these prognostic indicators in early endometrial carcinoma is discussed. © 1991.
引用
收藏
页码:142 / 145
页数:4
相关论文
共 50 条
  • [31] NEUROENDOCRINE DIFFERENTIATION IN PROSTATIC ADENOCARCINOMA IS NOT AN INDEPENDENT PROGNOSTIC INDICATOR
    WRIGHT, C
    GRIGNON, D
    SHUM, D
    PORTER, A
    LABORATORY INVESTIGATION, 1992, 66 (01) : A61 - A61
  • [32] Androgen Receptor Pathway As a Prognostic Indicator in Esophageal Adenocarcinoma
    Smith, Eric
    Palethorpe, Helen M.
    Ruszkiewicz, Andrew
    Leach, Damien
    Need, Eleanor
    Drew, Paul
    GASTROENTEROLOGY, 2015, 148 (04) : S356 - S356
  • [33] Prognostic significance of solid growth in endometrioid endometrial adenocarcinoma
    Serra Akar
    Zeliha Esin Çelik
    Sıddıka Fındık
    Tolgay Tuyan İlhan
    Fedi Ercan
    Çetin Çelik
    International Journal of Clinical Oncology, 2020, 25 : 195 - 202
  • [34] ENDOMETRIAL ADENOCARCINOMA, ADJUVANT RADIOTHERAPY TAILORED TO PROGNOSTIC FACTORS
    MEERWALDT, JH
    HOEKSTRA, CJM
    VANPUTTEN, WLJ
    TJOKROWARDOJO, AJS
    KOPER, PCM
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1990, 18 (02): : 299 - 304
  • [35] Metabolic syndrome is an independent prognostic factor for endometrial adenocarcinoma
    Ni, J.
    Zhu, T.
    Zhao, L.
    Che, F.
    Chen, Y.
    Shou, H.
    Yu, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (10): : 835 - 839
  • [36] Prognostic significance of hysteroscopic imaging in endometrioid endometrial adenocarcinoma
    Garuti, G
    De Giorgi, O
    Sambruni, I
    Cellani, F
    Luerti, M
    GYNECOLOGIC ONCOLOGY, 2001, 81 (03) : 408 - 413
  • [37] STORMAL EOSINOPHILIA - A FAVORABLE PROGNOSTIC INDICATOR IN COLONIC ADENOCARCINOMA
    KEITH, EF
    PRETLOW, TP
    PITTS, AM
    CRYAR, AK
    PRETLOW, TG
    FEDERATION PROCEEDINGS, 1982, 41 (03) : 409 - 409
  • [38] Prognostic Importance of Lymph-Vascular Space Involvement in Stage I Endometrioid Type Endometrial Cancer
    Kose, Caner
    Meydanli, Mehmet Mutlu
    BEZMIALEM SCIENCE, 2023, 11 (03): : 254 - 259
  • [39] NODAL INVOLVEMENT AS PROGNOSTIC INDICATOR IN PROSTATIC-CARCINOMA
    PROUT, GR
    GRIFFIN, PP
    DALY, JJ
    SHIPLEY, WU
    UROLOGY, 1981, 17 (03) : 72 - 79
  • [40] Angiogenesis factor in endometrial carcinoma: A new prognostic indicator? Discussion
    Fortunato, SJ
    Besinger, RE
    AlanisAmezcua, JM
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (06) : 1884 - 1884